Smartleaf Asset Management’s Strata Critical Medical Inc SRTA Stock Holding History

Smartleaf Asset Management’s Portfolio SRTA Stock Details SRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.18K	Buy	+623	New	+$3.39K	﹤0.01%	2883

Other funds holding SRTA

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

AIC

AWM Investment Company New York $1.04B AUM 103.31% 1-Year Est. Return

Pillsbury Lake Capital San Francisco, California $262M AUM 27.78% 1-Year Est. Return

First Eagle Investment Management New York $63.7B AUM 20.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $123B AUM 30.05% 1-Year Est. Return

Smartleaf Asset Management's SRTA Position: Q3 2026 in Review

Smartleaf Asset Management opened a new position in Strata Critical Medical Inc (SRTA) in Q3 2026: 623 shares worth $3.18K. The stake represents ﹤0.01% of the portfolio and ranks #2883 among its holdings.

120 funds tracked by Wall St. Rank hold SRTA as of Q3 2026.

Smartleaf Asset Management held 623 shares of Strata Critical Medical Inc worth $3.18K as of Q3 2026.
Strata Critical Medical Inc was a new Smartleaf Asset Management position in Q3 2026.
Strata Critical Medical Inc made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q3 2026, its #2883 holding.
120 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q3 2026.

Based on Smartleaf Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.